About Denvax
Denvax is a Healthcare company based in Delhi (India) founded in 2004. It operates a dedicated hospital specializing in cancer care and treatment. It operates on a B2C model. Its Indian entity Optimum Therapeutics Private Limited reported revenue of ₹23.73 Cr. Its focus areas include Hospitals, Oncology and Cancer Treatment. Its competitors include HCG, Cytecare, CION Cancer Clinics, American Oncology Institute and Omega Hospitals and 3 more; 7 of its 8 listed competitors have raised funding.
Company details
Denvax, established in 2004, excels in providing healthcare solutions, hospitals, oncology, and cancer treatment. Operates a dedicated hospital specializing in cancer care and treatment. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Delhi, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website denvaxindia.com
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Optimum Therapeutics Private Limited
- Date of Incorporation 13 Dec, 2011
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹23.73 Cr
FY 2024 · +16% YoY
- Net Profit₹1.74 Cr
FY 2024 · 7% margin
- EBITDA₹3.32 Cr
FY 2024 · 14% margin
Associated legal entities of Denvax
Denvax operates through Optimum Therapeutics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Optimum Therapeutics Private Limited CIN U85100DL2011PTC228675 | Active | 13 Dec 2011 | New Delhi, Delhi | ₹23.7 Cr | – | 2 | View details |
Apps and channels of Denvax
its YouTube channel Health Wealth & Lifestyle has 1.68M subscribers and 30 videos.
Videos from Denvax
The most watched videos on Denvax's YouTube channel, Health Wealth & Lifestyle (1.68M subscribers). Click a video to play it here.
More on Health Wealth & Lifestyle .
Board of directors of Optimum Therapeutics Private Limited (Denvax)
Optimum Therapeutics Private Limited is the primary company behind Denvax. The board of Optimum Therapeutics Private Limited currently have 2 directors; the longest-serving is Sharmin Yaqin, appointed in 2011.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sharmin Yaqin DIN 01579448 | Director | 13 Dec 2011 | 14 yrs 10 mo | Optimum Therapeutics Private Limited |
| Jamal Anono Khan DIN 00329984 | Director | 13 Dec 2011 | 14 yrs 10 mo | Optimum Therapeutics Private Limited |
People of Denvax
1 people are tracked at Denvax (1 in team).
| Name | Role | Group |
|---|---|---|
Dr. Jamal A. Khan and Dr Sharmin Yaqin | Founders | Team |
Complete people profiles for Denvax
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Denvax
Figures of Optimum Therapeutics Private Limited, the primary company behind Denvax, for FY 2024. Revenue was ₹23.73 Cr (+16% year on year). Net profit was ₹1.74 Cr (7% margin). EBITDA was ₹3.32 Cr (14% margin). Revenue has grown at a compounded annual rate of +15% over three years and +16% over five years.
- ₹23.73 CrRevenue · FY 2024 · +16% YoY
- ₹1.74 CrNet profit · 7% margin
- ₹3.32 CrEBITDA · 14% margin
- ₹1 LakhPaid-up capital
- +15%Revenue CAGR, 3 years
- +16%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Optimum Therapeutics Private Limited are on its company page.
Detailed financial statements for Denvax
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Denvax
Denvax has 8 listed competitors in our database, 7 of them funded. They include HCG, Cytecare, CION Cancer Clinics, American Oncology Institute and Omega Hospitals, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hcgoncology.com | 1989 | Bengaluru, India | $36.59M | 3,273 | Chain of oncology hospitals | |
| cytecare.com | 2014 | Bengaluru, India | $78.45M | 264 | Oncology hospitals chain offering specialized cancer treatments. | |
| cioncancerclinics.com | 2019 | Hyderabad, India | $10.87M | 119 | Cancer treatments and support are provided by a clinic chain. | |
| americanoncology.com | 2006 | Hyderabad, India | $4.19M | 1,231 | Cancer care is provided through a chain of specialized hospitals. | |
| omegahospitals.com | 2010 | Hyderabad, India | $59.94M | 1,101 | Specialized oncology treatments are offered by a hospital chain. | |
| mgcancerhospital.com | 2005 | Visakhapatnam, India | $1.3M | – | Cancer care is delivered via a chain of accredited hospitals. | |
| cancerhealercenter.com | 1997 | Delhi, India | – | 15 | Operates a chain of hospitals dedicated to cancer care and treatment. | |
| iociindia.com | 2005 | Noida, India | $3.26M | – | Cancer care treatment hospital providing diagnosis and treatment programs for various types of cancer |
Detailed competitors of Denvax
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Oncology
10 companies that operate in the same segment as Denvax (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Denvax
Denvax was founded in 2004.
Denvax is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind Denvax, Optimum Therapeutics Private Limited, reported revenue of ₹23.73 Cr for FY 2024, up 16% year on year.
Denvax, established in 2004, excels in providing healthcare solutions, hospitals, oncology, and cancer treatment. Operates a dedicated hospital specializing in cancer care and treatment. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
Denvax's top competitors include HCG, Cytecare and CION Cancer Clinics.
Denvax operates through Optimum Therapeutics Private Limited.
The legal entities of Denvax currently have 2 directors, including Sharmin Yaqin, Jamal Anono Khan.